Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 56.01
(-0.53%)
CNY 56.01
(-0.53%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 507.41 Million CNY | 54.07% |
| 2022 | 258.66 Million CNY | -32.72% |
| 2021 | 384.43 Million CNY | 47.54% |
| 2020 | 260.56 Million CNY | -40.51% |
| 2019 | 437.96 Million CNY | -1.16% |
| 2018 | 443.12 Million CNY | 6.64% |
| 2017 | 415.51 Million CNY | 11.43% |
| 2016 | 372.9 Million CNY | 16.04% |
| 2015 | 321.35 Million CNY | 47.27% |
| 2014 | 218.21 Million CNY | 52.82% |
| 2013 | 142.79 Million CNY | 13.48% |
| 2012 | 125.83 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 134.2 Million CNY | 37.94% |
| 2024 Q3 | 96.84 Million CNY | -27.84% |
| 2024 Q1 | 97.29 Million CNY | 8.81% |
| 2023 FY | 398.53 Million CNY | 54.07% |
| 2023 Q4 | 89.41 Million CNY | -35.64% |
| 2023 Q3 | 138.92 Million CNY | 24.22% |
| 2023 Q2 | 111.83 Million CNY | 32.06% |
| 2023 Q1 | 84.68 Million CNY | 358.69% |
| 2022 FY | 258.66 Million CNY | -32.72% |
| 2022 Q4 | 18.46 Million CNY | -85.97% |
| 2022 Q3 | 131.58 Million CNY | 1019.54% |
| 2022 Q2 | -14.3 Million CNY | -132.14% |
| 2022 Q1 | 44.52 Million CNY | 282.77% |
| 2021 Q3 | 35.91 Million CNY | -69.29% |
| 2021 Q4 | -24.35 Million CNY | -167.83% |
| 2021 FY | 384.43 Million CNY | 47.54% |
| 2021 Q2 | 116.94 Million CNY | 57.39% |
| 2021 Q1 | 74.3 Million CNY | -15.46% |
| 2020 Q1 | -73.02 Million CNY | -337.69% |
| 2020 Q4 | 87.89 Million CNY | 25.75% |
| 2020 Q3 | 69.89 Million CNY | 765.37% |
| 2020 Q2 | 8.07 Million CNY | 111.06% |
| 2020 FY | 260.56 Million CNY | -40.51% |
| 2019 Q4 | 30.72 Million CNY | -56.57% |
| 2019 FY | 437.96 Million CNY | -1.16% |
| 2019 Q1 | 73.8 Million CNY | -16.69% |
| 2019 Q3 | 70.75 Million CNY | -44.3% |
| 2019 Q2 | 127.02 Million CNY | 72.11% |
| 2018 FY | 443.12 Million CNY | 6.64% |
| 2018 Q4 | 88.59 Million CNY | 0.0% |
| 2018 Q3 | 88.59 Million CNY | -12.06% |
| 2018 Q1 | 100.74 Million CNY | -2.0% |
| 2018 Q2 | 100.74 Million CNY | 0.0% |
| 2017 FY | 415.51 Million CNY | 11.43% |
| 2017 Q4 | 102.8 Million CNY | 0.0% |
| 2017 Q3 | 102.8 Million CNY | 23.4% |
| 2017 Q2 | 83.3 Million CNY | 0.0% |
| 2017 Q1 | 83.3 Million CNY | 11.45% |
| 2016 Q2 | 67.45 Million CNY | 0.0% |
| 2016 Q4 | 74.75 Million CNY | 0.0% |
| 2016 Q3 | 74.75 Million CNY | 10.82% |
| 2016 Q1 | 67.45 Million CNY | 48.52% |
| 2016 FY | 372.9 Million CNY | 16.04% |
| 2015 FY | 321.35 Million CNY | 47.27% |
| 2015 Q3 | 45.41 Million CNY | -31.07% |
| 2015 Q2 | 65.88 Million CNY | 0.0% |
| 2015 Q1 | 65.88 Million CNY | 31.37% |
| 2015 Q4 | 45.41 Million CNY | 0.0% |
| 2014 Q1 | 43.56 Million CNY | 28.76% |
| 2014 Q4 | 50.15 Million CNY | 0.0% |
| 2014 Q2 | 43.56 Million CNY | 0.0% |
| 2014 FY | 218.21 Million CNY | 52.82% |
| 2014 Q3 | 50.15 Million CNY | 15.12% |
| 2013 Q2 | 37.55 Million CNY | 0.0% |
| 2013 Q3 | 33.83 Million CNY | -9.91% |
| 2013 Q4 | 33.83 Million CNY | 0.0% |
| 2013 FY | 142.79 Million CNY | 13.48% |
| 2013 Q1 | 37.55 Million CNY | 0.0% |
| 2012 FY | 125.83 Million CNY | 0.0% |